mtr.

Help make this better💜

Contribute here

Urolithiasis

Icon

What You Will Learn

After reading this note, you should be able to...

  • This content is not available yet.
Read More 🍪
Icon


    • Crystals bound by muco-protein (Matrix)
    • Normally present in urine in solution
    • Physiological substances keep the crystals in solution - stone inhibitors!

    STONE FORMING FACTORS

    • Uric acid
    • Calcium phosphate
    • Triple phosphate
    • Cystine crystal
    • Oxalate & Infection

    STONE ANTI-FORMING FACTORS

    • Magnesium
    • Citrate
    • Pyrophosphate
    • Nephrocalcin
    • Tamm-Horsfall glycoprotein

    • Increase in the quantity and concentration of the crystal forming constituents in the urine and/or serum.
    • Decrease in inhibitors of crystallization and crystal growth
    • Risk factors - Family history, Dehydration, alkaline urine!
    • Nucleus Formation
    • Stasis/Obstruction

    R-I-N-D-I-S

    FACTORS FOR STONE FORMATION:

    • Increased crystalloid concentration
    • Relative - reduced urine volume
    • Absolute - excessive excretion of the crystals
    • Urinary reaction acts by altering the solubility of the crystals
    • Absence of stone-inhibitors

    Citrate - 50%, magnesium - 20%, pyrophosphates, macromolecules e.g., Glycosaminoglycan, Tamm Horsfall protein, Nephrocalcin, RNA

    PROCESS OF STONE FORMATION

    • Phase of Nucleation - precipitation of crystal in a state of super saturated solution
    • Phase of Growth and Aggregation - the embryo nuclei enlarge in size
    • Phase of Trapping - large crystal aggregate is now entrapped in some part of renal anatomy
    • Phase of 'Stone' Formation - entrapped crystals now grow forming stone

    • Calcium Stones - 90% (oxalate, phosphate)
    • Oxalate Stones
    • Phosphate Stones
    • Uric Acid Stones

    COUP

    CALCIUM STONES:

    Crystals of oxalate:

    • Monohydrate (whewellite - bi-concave dumb-bells)
    • Dihydrate (Weddelite - bi-pyramid dodecahedron)

    Crystals of phosphate:

    • Calcium phosphate may be Brushite, Whitlockite, hydroxy-apatite or octa-calcium phosphate
    • Normal serum calcium: 9-11 mg% (50% bound to protein)
    • Absorptive hypercalciuria
    • Normal urinary excretion of calcium: 150 mg/day

    Factors: age, sex, climate, diet. >300 mg/day = hypercalciuria

    (>4 mg/kg-1/day)

    Hypercalciuria: >300 mg/day, may be associated with:

    • Hypercalcaemia: (hyperparathyroidism - absorptive/resorptive)
    • Normo-calcaemia: present in 95% of cases
      • Absorptive hypercalciuria
      • Renal hypercalciuria - primary renal tubular leakage of calcium that is dependent on Vit D and parathormone
    • Idiopathic hypercalciuria
    • Hyperparathyroidism hypercalciuria
    • Secondary hypercalcaemia
    • Renal Tubular Acidosis
    • Medullary sponge Kidney

    OXALATE STONES

    • Commonest renal stone
    • Calcium-oxalate precipitation is inhibited by: mucoproteins, urea, magnesium, pyrophosphate, etc.
    • Natural sources: rhubarb, spinach, pepper, tea, cocoa, etc.
    • Daily intake: 100-900 mg (10% absorbed)
    • Excreted via urine: 10-50 mg/day

    PHOSPHATE STONES

    • Phosphates are an integral part of the blood-bone urolithiasis circuit
    • Normal plasma level: 3-5 mg%, 13% bound, 90% filtered in the glomerulus, 20% excreted in urine
    • Pyrophosphate prevents crystallization
    • Calcium phosphate supersaturation causes Brushite stone

    Causes:

    • Hyperparathyroidism
    • Hypovitaminosis D
    • Alkaline urine - Triple phosphate stone
    • Prolonged immobilization

    Types:

    • Calcium phosphates - Octacalcium phosphate, Brushite, Whitlockite & Hydroxy-apatite
    • Magnesium phosphate - Newberyite
    • Triple phosphate - Struvite

    URIC ACID STONE

    • 5-7% of stones
    • Purine metabolism in humans results in uric acid (cf: highly soluble Allantoin in animals)
    • Normal plasma uric acid level: 2-5 mg%
    • 100% ultrafiltrate: nearly all reabsorbed in the proximal tubule
    • Daily urinary excretion: 600 mg
    • Dietary purine content has a direct relationship with urinary excretion

    Causes of uric acid stones

    • Gout: 20% in gout patients!
    • Secondary hyperuricaemia: tumors, TLS
    • Hyperacid uric
    • Ileostomy
    • Dietary purine: yeast, meat

    CYSTINE STONE

    Cystine is an amine of sulphur-containing amino acid

    Cystinuria: normal excretion is 30-50 mg/24h but in cystinuria, it increases to 300-1000 mg

    • It is a genetic renal tubular defect, of tubular reabsorption of cystine, based in chromosome 2
    • Excessive secretion of arginine, ornithine, lysine, and cystine - poor solubility, especially in acidic urine

    RINDIS!

    • Risk Factors: Family history, Dehydration, Urine pH
    • Increase in the quantity and concentration of the crystal forming constituents in the urine and/or serum
    • Nucleus Formation: inspissated pus, clump of bacteria, blood clot, a scar, FB
    • Decrease in inhibitors of crystallization and crystal growth: citrate, pyrophosphate
    • Infection: urea splitting organisms
    • Stasis

    • Silent stone
    • Fixed pain
    • Colicky pain
    • Gastro-intestinal symptoms
    • Infective symptoms
    • Retention of urine
    • Haematuria
    • Irritative bladder symptoms
    • Calculous anuria
    • Uraemic features

    • Urinalysis
    • Uro-bacteriology
    • Urinary biochemistry
      • Calcium: 300 mg
      • Cystine: >250 mg/gm of creatinine
      • Oxalate: >44 mg/day
      • Uric acid: >600 mg/day
      • Ammonium chloride test
    • Plain X-ray
    • USS
    • Intravenous Urography
    • CT Scan
      • NCCT
      • CT Urography or CECT
    • Blood Biochemistry
      • Plasma calcium
      • Inorganic phosphate
      • Uric acid
      • BUE/Cr, ALP
    • Endoscopy
    • Stone Analysis

    MEDICAL TREATMENT

    • Expectant Treatment:
      • Bed Rest
      • Antispasmodic
      • Liberal oral fluid
      • Diagnostic Investigation
      • Observation
    • Medical Expulsion Treatment:
      • Tamsulosin/Nifedipine
    • Prophylactic Medical Treatment:
      • Hydrotherapy
      • Diet
      • Control UTI
      • Oral Potassium Citrate

    SURGICAL TREATMENT

    • Indications
      • Stones too large for spontaneous passage, usually greater than 7 mm.
      • Stones associated with symptomatic infection
      • Stones causing impaired renal function
      • Stones causing persistent pain or worsening of symptom
      • Patient with only one kidney

    Close procedure:

    • Lithotripsy (Extracorporeal Shockwave lithotripsy (ESWL)
      • Noninvasive
    • Percutaneous Nephrolithotomy

    Open Procedure

    • Ureterolithotomy
    • Pyelolithotomy
    • Nephrolithotomy
    • Partial or total nephrectomy

    • Avoid protein intake: usually protein is restricted to 60g/day to decrease urinary excretion of calcium and uric acid.
    • A sodium intake of 3 to 4 g/day is recommended. Table salt and high-sodium foods should be reduced because sodium competes with calcium for reabsorption in the kidneys.
    • Low-calcium diets are not generally recommended, except for true absorptive hypercalciuria. Evidence shows that limiting calcium, especially in women, can lead to osteoporosis and does not prevent renal stones.
    • Avoid intake of oxalate-containing foods (e.g. spinach, strawberries, tea, peanuts, wheat bran).
    • During the day, drink fluids (ideally water) every 1 to 2 hours.
    • Drink two glasses of water at bedtime and an additional glass at each night time awakening to prevent urine from becoming too concentrated during the night.
    • Avoid activities leading to sudden increases in environmental temperatures that may cause excessive sweating and dehydration.
    • Contact your primary health care provider at the first sign of a urinary tract infection.

    Icon

    Practice Questions

    Check how well you grasp the concepts by answering the following questions...

    1. This content is not available yet.
    Read More 🍪
    Comment Icon

    Send your comments, corrections, explanations/clarifications and requests/suggestions

    here